Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4177G | ISIN: US71678J3086 | Ticker-Symbol:
NASDAQ
21.05.25 | 22:00
0,066 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PETROS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
PETROS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur PETROS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets161The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on...
► Artikel lesen
21.05.Petros Pharmaceuticals, Inc. - 8-K, Current Report2
20.05.Petros Pharmaceuticals partners with Innolitics for SaaS platform7
20.05.Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development3
20.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer474With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform. NEW YORK, NY / ACCESS Newswire / May 20, 2025...
► Artikel lesen
15.05.Petros Pharmaceuticals, Inc. - 10-Q, Quarterly Report4
06.05.Petros Pharmaceuticals verbessert KI für Rx-to-OTC-Wechselplattform13
PETROS PHARMACEUTICALS Aktie jetzt für 0€ handeln
06.05.Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform2
06.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform224Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petros...
► Artikel lesen
02.05.Petros Pharmaceuticals, Inc. - 8-K, Current Report1
01.05.Petros Pharmaceuticals schwenkt auf intelligente Gesundheitstechnologie um5
01.05.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches298Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again...
► Artikel lesen
29.04.Petros Pharmaceuticals gears up for Rx-to-OTC switch platform7
29.04.Petros Pharmaceuticals, Inc.: Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms340Company's AI and Big Data technology positioned to drive strong industry collaborationCompany also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmaceuticals...
► Artikel lesen
09.04.Petros Pharmaceuticals, Inc. - 8-K, Current Report1
20.03.Petros Pharmaceuticals enhances Rx-to-OTC switch technology7
20.03.Petros Pharmaceuticals verbessert Rx-to-OTC-Umstellungstechnologie4
20.03.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications457Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the counter...
► Artikel lesen
25.02.Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study445Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Petros Pharmaceuticals...
► Artikel lesen
21.02.Petros Pharmaceuticals, Inc. - 8-K, Current Report-
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1